This study was designed to assess the efficacy and safety of combination therapy of PAXIL and
benzodiazepine anxiolytics. PAXIL Tablet will be administered to patients with depression or
depressive episodes who have received Benzodiazepines for at least 4 weeks, and changes in
the symptoms of depression will be evaluated by use of the rate and extent of decrease in
Hamilton Rating Scale for Depression (HAM-D).